08:54 AM EST, 01/27/2025 (MT Newswires) -- Health care stocks were mixed premarket Monday, with The Health Care Select Sector SPDR Fund (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.3% lower.

Akero Therapeutics ( AKRO ) shares were up over 114% after the company said a phase 2b study of its lead product candidate efruxifermin showed a "statistically significant" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.